Trial Profile
Midazolam +/- GDC 0032 in patients with advanced solid tumours
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Dec 2013
Price :
$35
*
At a glance
- Drugs Taselisib (Primary) ; Midazolam
- Indications Solid tumours
- Focus Pharmacokinetics
- 17 Dec 2013 New trial record
- 23 Oct 2013 Results presented at the 25th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.